Elutia Plans FDA Submission for Surgical Matrix Targeting Infections in Reconstructive Surgery
The antibiotic-eluting matrix met performance endpoints in a rabbit study, with no viable MRSA or E. coli bacteria recovered from the matrix or surrounding tissue.